not a claim of clinical outcome
We're not just selling peptides
These include severe abdominal pain, persistent vomiting with inability to tolerate fluids, visual changes (especially for people with diabetes and existing retinopathy), signs of allergic reaction (rash, difficulty breathing, facial swelling), right upper quadrant pain with fever or jaundice (possible gallbladder disease), or symptoms of thyroid tumors (neck mass, hoarseness, difficulty swallowing)
Gupta NA, Mells J, Dunham RM, Grakoui A, Handy J, Saxena NK, Anania FA
El documento exhorta al fortalecimiento regulatorio y de farmacovigilancia, lo cual contempla, entre otros aspectos, reforzar los sistemas nacionales de farmacovigilancia activa y pasiva, integrando mecanismos de deteccin temprana de eventos adversos asociados al uso de agonistas GLP-1, particularmente aquellos relacionados con uso fuera de indicacin, automedicacin o adquisicin por canales no autorizados